Zheng Quan Zhi Xing·2025-07-03 16:15Summary of Key Points Core Viewpoint - Tian Sheng Pharmaceutical Group Co., Ltd. has approved a guarantee for its wholly-owned subsidiary, Tian Sheng Pharmaceutical Group Chongqing Drug Research Institute Co., Ltd., to secure a loan of RMB 5 million from Chongqing Bank for a term of three years [1][2]. Group 1: Guarantee Overview - The board of directors approved the guarantee for the subsidiary to apply for credit from Chongqing Bank [1]. - The loan amount is RMB 5 million with a repayment period of three years [2]. - The company signed a guarantee contract and a mortgage contract with Chongqing Bank to secure the loan [1][2]. Group 2: Contract Details - The guarantee contract specifies that Tian Sheng Pharmaceutical Group Co., Ltd. is the guarantor for the loan taken by its subsidiary [2]. - The principal amount of the loan is RMB 5 million, with interest and penalties calculated as per the main contract [2]. - The mortgage contract also states that the company will cover all related costs, including legal fees and other expenses incurred during the enforcement of the mortgage [2]. Group 3: Financial Overview of the Subsidiary - Tian Sheng Pharmaceutical Group Chongqing Drug Research Institute Co., Ltd. was established on March 22, 2010, with a registered capital of RMB 50 million [3][4]. - The total assets of the subsidiary as of December 31, 2024, were RMB 5,098.31 million, with total liabilities of RMB 240.60 million [5]. - The subsidiary reported a net profit of RMB 125.17 million for the year ending December 31, 2024, but incurred a loss of RMB 212.66 million for the first quarter of 2025 [5]. Group 4: Guarantee Amounts - The total external guarantee amount for the company and its subsidiaries is RMB 202 million, with a total balance of RMB 152.24 million, representing 7.59% of the equity attributable to the parent company as of December 31, 2024 [5]. - There are no overdue guarantees or litigation issues related to external guarantees [5].